Search research articles
Contact Us
Filters
Showing results (1031-1040 of 1,520) with videos related to
Page
of 152
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2010
Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2
Christina M Annunziata, Amanda J Walker, Lori Minasian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 1999
A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancer
K S Bauer, W D Figg, J M Hamilton, et al.
American Journal of Clinical Oncology
|
June 1, 2002
Phase II neoadjuvant trial of paclitaxel by 96-hour continuous infusion (CIVI) in combination with cisplatin followed by chest radiotherapy for patients with stage III non-small-cell lung cancer
O S Breathnach, V Kasturi, F Kaye, et al.
Annals of Surgical Oncology
|
July 29, 2018
An Examination of Applicants and Factors Associated with Matriculation to Complex General Surgical Oncology Fellowship Training Programs
Michael M Wach, Samantha M Ruff, Reed I Ayabe, et al.
Cancer
|
March 3, 2007
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer
Edwin M Posadas, Meghan S Liel, Virginia Kwitkowski, et al.
Investigational New Drugs
|
August 26, 2006
Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer
Neelima Denduluri, James J Lee, Janice Walshe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Paclitaxel by 96-hour continuous infusion in combination with cisplatin: a phase I trial in patients with advanced lung cancer
M S Georgiadis, B S Schuler, J E Brown, et al.
American Journal of Surgery
|
January 20, 2016
Significance of preoperative radiographic pancreatic density in predicting pancreatic fistula after surgery for pancreatic neuroendocrine tumors
Yasmine Assadipour, Saïd C Azoury, Nicholas N Schaub, et al.
JTO Clinical and Research Reports
|
October 18, 2021
Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in <i>BAP1</i> Gene
Azam Ghafoor, Idrees Mian, Cathy Wagner, et al.
Critical Care (London, England)
|
February 17, 2007
Effect of positive end-expiratory pressure and tidal volume on lung injury induced by alveolar instability
Jeffrey M Halter, Jay M Steinberg, Louis A Gatto, et al.
Page
of 152
Search research articles
Search
Showing results (1031-1040 of 1,520) with videos related to
Sort By:
Page
of 152
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2010
Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2
Christina M Annunziata, Amanda J Walker, Lori Minasian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 1999
A pharmacokinetically guided Phase II study of carboxyamido-triazole in androgen-independent prostate cancer
K S Bauer, W D Figg, J M Hamilton, et al.
American Journal of Clinical Oncology
|
June 1, 2002
Phase II neoadjuvant trial of paclitaxel by 96-hour continuous infusion (CIVI) in combination with cisplatin followed by chest radiotherapy for patients with stage III non-small-cell lung cancer
O S Breathnach, V Kasturi, F Kaye, et al.
Annals of Surgical Oncology
|
July 29, 2018
An Examination of Applicants and Factors Associated with Matriculation to Complex General Surgical Oncology Fellowship Training Programs
Michael M Wach, Samantha M Ruff, Reed I Ayabe, et al.
Cancer
|
March 3, 2007
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer
Edwin M Posadas, Meghan S Liel, Virginia Kwitkowski, et al.
Investigational New Drugs
|
August 26, 2006
Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer
Neelima Denduluri, James J Lee, Janice Walshe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Paclitaxel by 96-hour continuous infusion in combination with cisplatin: a phase I trial in patients with advanced lung cancer
M S Georgiadis, B S Schuler, J E Brown, et al.
American Journal of Surgery
|
January 20, 2016
Significance of preoperative radiographic pancreatic density in predicting pancreatic fistula after surgery for pancreatic neuroendocrine tumors
Yasmine Assadipour, Saïd C Azoury, Nicholas N Schaub, et al.
JTO Clinical and Research Reports
|
October 18, 2021
Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in <i>BAP1</i> Gene
Azam Ghafoor, Idrees Mian, Cathy Wagner, et al.
Critical Care (London, England)
|
February 17, 2007
Effect of positive end-expiratory pressure and tidal volume on lung injury induced by alveolar instability
Jeffrey M Halter, Jay M Steinberg, Louis A Gatto, et al.
Page
of 152